Trials
Search / Trial NCT06427707

The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries.

Launched by AIN SHAMS UNIVERSITY · May 20, 2024

Trial Information

Current as of February 12, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how adding two different medications, Propofol and Ketamine, to magnesium and lidocaine infusions can help reduce bleeding during nasal surgeries. The goal is to improve the surgical experience by ensuring the surgical team has a clear view of the area they are working on, which is important for the safety and success of the procedure.

To participate in this study, you need to be between 6 and 74 years old and scheduled for an elective nasal surgery. You should be in good health overall, without serious conditions like uncontrolled high blood pressure, heart disease, or issues with your kidneys, liver, or brain. If you are pregnant or have certain blood disorders, you won't be eligible. If you join the trial, you will receive either Propofol or Ketamine alongside the other medications during your surgery, and the doctors will monitor how well it works in reducing bleeding. This study is currently recruiting participants, so if you think you might qualify, it’s a good idea to talk to your healthcare provider for more information.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA I-II,
  • scheduled for elective nasal surgery
  • Exclusion Criteria:
  • Patients with uncontrolled hypertension.
  • Patients with cardiac disease.
  • Patients with renal, hepatic or cerebral insufficiency.
  • Patients with coagulopathy or receiving drugs influencing blood coagulation.
  • Anaemia, haemoglobinopathies or polycythemia.
  • Pregnancy.
  • Patients with known sensitivity to any of the study drug.

About Ain Shams University

Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.

Locations

Cairo, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0